The BMJ/MAGIC Group performed a systematic review to determine which patients may benefit from SGLT-2 inhibitors or GLP-1 receptor agonists
the summary statistics were generated using SAS (version 9.4)
Water/Aqua/Eau, Cyclopentasiloxane, Cyclohexasiloxane, Glycerin, PEG-10 Dimethicone, Talc, Hexyl Laurate, Dipropylene Glycol, C12-15 Alkyl Benzoate, Niacinamide, Diphenylsiloxy Phenyl Trimethicone, Disteardimonium Hectorite, Citrus Aurantium Bergamia (Bergamot) Fruit Oil, Citrus Limon (Lemon) Peel Oil, Citrus Aurantifolia (Lime) Oil, Pinus Sylvestris (Pine) Leaf Oil, Citrus Aurantium Dulcis (Orange) Peel Oil, Adenosine, Allantoin, Ethylhexylglycerin, Trihydroxystearin, Polyglyceryl-6 Polyricinoleate, Methicone, Dimethicone, Dimethicone/Vinyl Dimethicone Crosspolymer, 1,2-Hexanediol, Triethoxycaprylylsilane, Magnesium Sulfate, Eucalyptus Globulus Leaf Oil, Limonene, Tocopherol, BHT, Phenoxyethanol, Titanium Dioxide (CI 77891), Iron Oxides (CI 77492), Iron Oxides (CI 77491), Iron Oxides (CI 77499)
C.R: Investigation
Roughly half of the participants took semaglutide and half took a placebo
Ultimately, the duration of Semaglutide treatment varies depending on factors like your starting weight, weight loss goals, your response to the medication, and your lifestyle regarding diet and exercise
